ArticleFrontiers in immunology2025

Combining interleukin 6 and EBV DNA levels predicts survival outcomes for patients with recurrent or metastatic nasopharyngeal carcinoma receiving chemoimmunotherapy.

Ya Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.